Ilya Shmulevich
Ilya Shmulevich
Verified email at systemsbiology.org - Homepage
TitleCited byYear
Comprehensive molecular characterization of human colon and rectal cancer
Cancer Genome Atlas Network
Nature 487 (7407), 330, 2012
39812012
The somatic genomic landscape of glioblastoma
CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ...
Cell 155 (2), 462-477, 2013
24522013
The cancer genome atlas pan-cancer analysis project
JN Weinstein, EA Collisson, GB Mills, KRM Shaw, BA Ozenberger, ...
Nature genetics 45 (10), 1113, 2013
24062013
Comprehensive molecular characterization of gastric adenocarcinoma
Cancer Genome Atlas Research Network
Nature 513 (7517), 202-209, 2014
21822014
Integrated genomic characterization of endometrial carcinoma
DA Levine, Cancer Genome Atlas Research Network
Nature 497 (7447), 67-73, 2013
21432013
Probabilistic Boolean networks: a rule-based uncertainty model for gene regulatory networks
I Shmulevich, ER Dougherty, S Kim, W Zhang
Bioinformatics 18 (2), 261-274, 2002
15942002
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ...
Cell 161 (7), 1681-1696, 2015
10912015
Integrated genomic characterization of papillary thyroid carcinoma
N Agrawal, R Akbani, BA Aksoy, A Ally, H Arachchi, SL Asa, JT Auman, ...
Cell 159 (3), 676-690, 2014
10892014
The molecular taxonomy of primary prostate cancer
A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ...
Cell 163 (4), 1011-1025, 2015
10042015
From Boolean to probabilistic Boolean networks as models of genetic regulatory networks
I Shmulevich, ER Dougherty, W Zhang
Proceedings of the IEEE 90 (11), 1778-1792, 2002
5562002
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
4932018
Comprehensive and integrative genomic characterization of hepatocellular carcinoma
A Ally, M Balasundaram, R Carlsen, E Chuah, A Clarke, N Dhalla, RA Holt, ...
Cell 169 (7), 1327-1341. e23, 2017
4772017
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
4652018
Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer
D Yang, S Khan, Y Sun, K Hess, I Shmulevich, AK Sood, W Zhang
Jama 306 (14), 1557-1565, 2011
3922011
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
3682018
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
3222018
Gene perturbation and intervention in probabilistic Boolean networks
I Shmulevich, ER Dougherty, W Zhang
Bioinformatics 18 (10), 1319-1331, 2002
3202002
Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer
D Yang, Y Sun, L Hu, H Zheng, P Ji, CV Pecot, Y Zhao, S Reynolds, ...
Cancer cell 23 (2), 186-199, 2013
3182013
Function of C/EBPδ in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals
V Litvak, SA Ramsey, AG Rust, DE Zak, KA Kennedy, AE Lampano, ...
Nature immunology 10 (4), 437, 2009
2802009
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
2712018
The system can't perform the operation now. Try again later.
Articles 1–20